• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies.用邻近诱导调节剂靶向tau蛋白:对抗tau蛋白病的新前沿。
ACS Pharmacol Transl Sci. 2025 Feb 10;8(3):654-672. doi: 10.1021/acsptsci.4c00733. eCollection 2025 Mar 14.
2
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
6
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Chemical Strategies to Modulate and Manipulate RNA Epigenetic Modifications.调控和操纵RNA表观遗传修饰的化学策略
Acc Chem Res. 2025 Jun 3;58(11):1727-1741. doi: 10.1021/acs.accounts.4c00844. Epub 2025 Mar 18.
10
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.用于预防成人围手术期意外低温引起并发症的主动体表升温系统。
Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD009016. doi: 10.1002/14651858.CD009016.pub2.

引用本文的文献

1
PROTAC Technology as a New Tool for Modern Pharmacotherapy.PROTAC技术作为现代药物治疗的新工具。
Molecules. 2025 May 11;30(10):2123. doi: 10.3390/molecules30102123.
2
Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable Development Goals.药物化学:实现全球可持续发展目标的关键驱动力。
J Med Chem. 2025 Apr 10;68(7):6916-6931. doi: 10.1021/acs.jmedchem.4c03016. Epub 2025 Mar 20.

本文引用的文献

1
Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy.通过邻近诱导模式调节磷酸化用于癌症治疗
J Med Chem. 2024 Dec 26;67(24):21695-21716. doi: 10.1021/acs.jmedchem.4c02624. Epub 2024 Dec 9.
2
Are lecanemab and donanemab disease-modifying therapies?lecanemab和donanemab是改变疾病进程的疗法吗?
Alzheimers Dement. 2024 Sep;20(9):6659-6661. doi: 10.1002/alz.14114. Epub 2024 Aug 3.
3
FDA approves third anti-amyloid antibody for Alzheimer disease.美国食品药品监督管理局批准第三种用于治疗阿尔茨海默病的抗淀粉样蛋白抗体。
Nat Rev Drug Discov. 2024 Aug;23(8):571. doi: 10.1038/d41573-024-00116-1.
4
A new tau dephosphorylation-targeting chimera for the treatment of tauopathies.一种新的靶向 Tau 去磷酸化的嵌合体,用于治疗 Tau 病。
Acta Pharmacol Sin. 2024 Nov;45(11):2267-2276. doi: 10.1038/s41401-024-01326-4. Epub 2024 Jul 2.
5
Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer's disease model mice.通过蛋白酶靶向嵌合体选择性降解过度磷酸化的tau蛋白可改善阿尔茨海默病模型小鼠的认知功能。
Front Pharmacol. 2024 Jun 11;15:1351792. doi: 10.3389/fphar.2024.1351792. eCollection 2024.
6
Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease.仑卡奈单抗治疗早期阿尔茨海默病患者的成本效益分析
Neurology. 2024 Apr 9;102(7):e209218. doi: 10.1212/WNL.0000000000209218. Epub 2024 Mar 14.
7
Proximity-Induced Pharmacology for Amyloid-Related Diseases.淀粉样相关疾病的临近诱导药理学。
Cells. 2024 Mar 4;13(5):449. doi: 10.3390/cells13050449.
8
Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials.阿尔茨海默病临床试验中揭盲对观察到的治疗效果的潜在影响。
Alzheimers Dement. 2024 Apr;20(4):3119-3125. doi: 10.1002/alz.13690. Epub 2024 Feb 21.
9
Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer's disease and related tauopathies.针对阿尔茨海默病和相关 tau 病的 tau 去磷酸化靶向嵌合体的生成。
Sci Bull (Beijing). 2024 Apr 30;69(8):1137-1152. doi: 10.1016/j.scib.2024.01.019. Epub 2024 Jan 19.
10
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.一篇关于用于tau神经原纤维缠结正电子发射断层扫描成像的氟替卡匹文献综述。
Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024.

用邻近诱导调节剂靶向tau蛋白:对抗tau蛋白病的新前沿。

Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies.

作者信息

Uliassi Elisa, Bolognesi Maria Laura, Milelli Andrea

机构信息

Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6, Bologna 40126, Italy.

Department for Life Quality Studies, Alma Mater Studiorum - University of Bologna, Corso d'Augusto 237, Rimini 47921, Italy.

出版信息

ACS Pharmacol Transl Sci. 2025 Feb 10;8(3):654-672. doi: 10.1021/acsptsci.4c00733. eCollection 2025 Mar 14.

DOI:10.1021/acsptsci.4c00733
PMID:40109749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11915046/
Abstract

Dysregulation of correct protein tau homeostasis represents the seed for the development of several devastating central nervous system disorders, known as tauopathies, that affect millions of people worldwide. Despite massive public and private support to research funding, these diseases still represent unmet medical needs. In fact, the tau-targeting tools developed to date have failed to translate into the clinic. Recently, taking advantage of the modes that nature uses to mediate the flow of information in cells, researchers have developed a new class of molecules, called proximity-inducing modulators, which exploit spatial proximity to modulate protein function(s) and redirect cellular processes. In this perspective, after a brief discussion about tau protein and the classic tau-targeting approaches, we will discuss the different classes of proximity-inducing modulators developed so far and highlight the applications to modulate tau protein's function and tau-induced toxicity.

摘要

正确的蛋白质tau稳态失调是几种毁灭性中枢神经系统疾病(即tau蛋白病)发展的根源,这些疾病影响着全球数百万人。尽管获得了大量公共和私人资金支持用于研究,但这些疾病仍存在未满足的医疗需求。事实上,迄今为止开发的靶向tau蛋白的工具未能转化为临床应用。最近,研究人员利用自然界中用于介导细胞内信息流的方式,开发了一类新的分子,称为邻近诱导调节剂,这类分子利用空间邻近性来调节蛋白质功能并重新引导细胞过程。从这个角度来看,在简要讨论tau蛋白和经典的靶向tau蛋白的方法之后,我们将讨论迄今为止开发的不同类别的邻近诱导调节剂,并强调其在调节tau蛋白功能和tau诱导的毒性方面的应用。